These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 8625241)
1. Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma. Li SF; Shiozawa T; Nakayama K; Nikaido T; Fujii S Cancer; 1996 Jan; 77(2):321-9. PubMed ID: 8625241 [TBL] [Abstract][Full Text] [Related]
2. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Nikaido T; Li SF; Shiozawa T; Fujii S Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947 [TBL] [Abstract][Full Text] [Related]
3. Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas. Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression. Nanbu K; Konishi I; Komatsu T; Mandai M; Yamamoto S; Kuroda H; Koshiyama M; Mori T Cancer; 1996 Jan; 77(2):330-8. PubMed ID: 8625242 [TBL] [Abstract][Full Text] [Related]
4. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211 [TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
7. bcl-2 and p53 in endometrial adenocarcinoma. Taskin M; Lallas TA; Barber HR; Shevchuk MM Mod Pathol; 1997 Jul; 10(7):728-34. PubMed ID: 9237185 [TBL] [Abstract][Full Text] [Related]
8. p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium. Horn LC; Richter CE; Einenkel J; Tannapfel A; Liebert UG; Leo C Ann Diagn Pathol; 2006 Aug; 10(4):193-6. PubMed ID: 16844559 [TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma. Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma. Suthipintawong C; Wejaranayang C; Vipupinyo C J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508 [TBL] [Abstract][Full Text] [Related]
12. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Giordano G; Gnetti L; Merisio C; Melpignano M Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204 [TBL] [Abstract][Full Text] [Related]
13. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Qiu C; Shan L; Yu M; Snyderwine EG Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591 [TBL] [Abstract][Full Text] [Related]
15. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study. Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803 [TBL] [Abstract][Full Text] [Related]
17. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression. Uchikawa J; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Oka K; Konishi I Cancer; 2003 Nov; 98(10):2207-13. PubMed ID: 14601091 [TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of sex steroid receptors and cell cycle-related molecules in adenocarcinoma in situ of the uterine cervix. Lu X; Shiozawa T; Nakayama K; Toki T; Nikaido T; Fujii S Int J Gynecol Pathol; 1999 Apr; 18(2):109-14. PubMed ID: 10202666 [TBL] [Abstract][Full Text] [Related]
19. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788 [TBL] [Abstract][Full Text] [Related]
20. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Jongen V; Briƫt J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]